ABO blood type has no effect on hepatocellular carcinoma recurrence after living donor liver transplantation in the Korean Organ Transplantation Registry study: a case–control study
ABO blood type does not predict HCC recurrence or overall survival. Clinical factors like beyond the Milan criteria and ABO-incompatibility remain critical in managing LDLT patients with HCC.
Authors
- Jongman KIM
- Jai Young CHO
- Jaehun Yang (ORCID: https://orcid.org/0000-0002-6256-3103)
- Man Ki Ju (ORCID: https://orcid.org/0000-0002-4112-7003)
- D. J. Joo
- Dong-Sik KIM
- S.J. Suh
- S. Hwang
- DongLak Choi
- Bong-Wan Kim
- Je Ho Ryu
- Kwang-Woong Lee
- Young Kyoung You
- Koo Jeong Kang
- Yang Won Nah
Institutions
- Ulsan College (KR)
- Seoul National University (KR)
- Yonsei University (KR)
- Korea University (KR)
- Samsung Medical Center (KR)
- Seoul National University Bundang Hospital (KR)
- Daegu Catholic University (KR)
- University of Ulsan (KR)
- Keimyung University Dongsan Medical Center (KR)
- Ulsan University Hospital (KR)
- Gangnam Severance Hospital (KR)
- Pusan National University Yangsan Hospital (KR)
- Keimyung University (KR)
- Ajou University (KR)
- Chung-Ang University (KR)
- Sungkyunkwan University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1097/js9.0000000000004816
- Primary Topic
- Blood groups and transfusion
- Type
- article
- Field-Weighted Citation Impact
- 0.00